WHV Investments’s Gilead Sciences GILD Stock Holding History

WHV Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.54M	Buy	+16,798	New	+$1.51M	0.83%	40

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WHV Investments's GILD Position: Q1 2016 in Review

WHV Investments opened a new position in Gilead Sciences (GILD) in Q1 2016: 16,798 shares worth $1.54M. The stake represents 0.83% of the portfolio and ranks #40 among its holdings.

1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

WHV Investments held 16,798 shares of Gilead Sciences worth $1.54M as of Q1 2016.
Gilead Sciences was a new WHV Investments position in Q1 2016.
Gilead Sciences made up 0.83% of WHV Investments's portfolio in Q1 2016, its #40 holding.
1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on WHV Investments's 13F filing for Q1 2016, filed 11 May 2016.